Detalhe da pesquisa
1.
TBCRC 002: a phase II, randomized, open-label trial of preoperative letrozole with or without bevacizumab in postmenopausal women with newly diagnosed stage 2/3 hormone receptor-positive and HER2-negative breast cancer.
Breast Cancer Res
; 22(1): 22, 2020 02 18.
Artigo
Inglês
| MEDLINE | ID: mdl-32070401
2.
Safety and efficacy of long-term treatment of chronic/persistent ITP with eltrombopag: final results of the EXTEND study.
Blood
; 130(23): 2527-2536, 2017 12 07.
Artigo
Inglês
| MEDLINE | ID: mdl-29042367
3.
Changes in health-related quality of life with long-term eltrombopag treatment in adults with persistent/chronic immune thrombocytopenia: Findings from the EXTEND study.
Am J Hematol
; 94(2): 200-208, 2019 02.
Artigo
Inglês
| MEDLINE | ID: mdl-30417939
4.
Artificial intelligence and machine learning for early detection and diagnosis of colorectal cancer in sub-Saharan Africa.
Gut
; 71(7): 1259-1265, 2022 07.
Artigo
Inglês
| MEDLINE | ID: mdl-35418482
5.
Treatment of immune thrombocytopenia with eltrombopag in patients who had and who had not received prior rituximab: post-hoc analysis of the EXTEND study.
Br J Haematol
; 196(2): 448-452, 2022 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34458977
6.
Academic Cancer Center Phase I Program Development.
Oncologist
; 22(4): 369-374, 2017 04.
Artigo
Inglês
| MEDLINE | ID: mdl-28314841
7.
Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine.
N Engl J Med
; 369(18): 1691-703, 2013 Oct 31.
Artigo
Inglês
| MEDLINE | ID: mdl-24131140
8.
Comparison of two dosing schedules for subcutaneous injections of low-dose anti-CD20 veltuzumab in relapsed immune thrombocytopenia.
Haematologica
; 101(11): 1327-1332, 2016 11.
Artigo
Inglês
| MEDLINE | ID: mdl-27515248
9.
Safety and efficacy of eltrombopag for treatment of chronic immune thrombocytopenia: results of the long-term, open-label EXTEND study.
Blood
; 121(3): 537-45, 2013 Jan 17.
Artigo
Inglês
| MEDLINE | ID: mdl-23169778
10.
Repeated short-term use of eltrombopag in patients with chronic immune thrombocytopenia (ITP).
Br J Haematol
; 160(4): 538-46, 2013 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-23278590
11.
Low-dose anti-CD20 veltuzumab given intravenously or subcutaneously is active in relapsed immune thrombocytopenia: a phase I study.
Br J Haematol
; 162(5): 693-701, 2013 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-23829485
12.
Eltrombopag for management of chronic immune thrombocytopenia (RAISE): a 6-month, randomised, phase 3 study.
Lancet
; 377(9763): 393-402, 2011 Jan 29.
Artigo
Inglês
| MEDLINE | ID: mdl-20739054
13.
Phase 1 Trial of ALRN-6924, a Dual Inhibitor of MDMX and MDM2, in Patients with Solid Tumors and Lymphomas Bearing Wild-type TP53.
Clin Cancer Res
; 27(19): 5236-5247, 2021 10 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34301750
14.
Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura.
N Engl J Med
; 357(22): 2237-47, 2007 Nov 29.
Artigo
Inglês
| MEDLINE | ID: mdl-18046028
15.
Targetable vulnerabilities in T- and NK-cell lymphomas identified through preclinical models.
Nat Commun
; 9(1): 2024, 2018 05 22.
Artigo
Inglês
| MEDLINE | ID: mdl-29789628
16.
Bendamustine in non-Hodgkin lymphoma: the double-agent that came from the Cold War.
Clin Lymphoma Myeloma
; 8 Suppl 1: S13-7, 2007 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-18282361
17.
Correction: Phase I Trial of ALRN-6924, a Dual Inhibitor of MDMX and MDM2, in Patients with Solid Tumors and Lymphomas Bearing Wild-type TP53.
Clin Cancer Res
; 28(2): 429, 2022 Jan 15.
Artigo
Inglês
| MEDLINE | ID: mdl-35045962
18.
Phase I/IIa study of cetuximab with gemcitabine plus carboplatin in patients with chemotherapy-naive advanced non-small-cell lung cancer.
J Clin Oncol
; 23(36): 9089-96, 2005 Dec 20.
Artigo
Inglês
| MEDLINE | ID: mdl-16301597
19.
Phase II study of a novel taxane (Cabazitaxel-XRP 6258) in previously treated advanced non-small cell lung cancer (NSCLC) patients.
Cancer Chemother Pharmacol
; 78(3): 509-15, 2016 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-27417317
20.
Treatment with ibritumomab tiuxetan radioimmunotherapy in patients with rituximab-refractory follicular non-Hodgkin's lymphoma.
J Clin Oncol
; 20(15): 3262-9, 2002 Aug 01.
Artigo
Inglês
| MEDLINE | ID: mdl-12149300